1. Home
  2. PBH

as of 11-28-2025 12:52pm EST

$59.46
$0.12
-0.20%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Chart Type:
Time Range:
Founded: 1996 Country:
United States
United States
Employees: N/A City: TARRYTOWN
Market Cap: 2.8B IPO Year: 2005
Target Price: $86.40 AVG Volume (30 days): 454.8K
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 4.04 EPS Growth: -1.41
52 Week Low/High: $57.25 - $90.04 Next Earning Date: 11-06-2025
Revenue: $1,110,479,000 Revenue Growth: -0.02%
Revenue Growth (this year): -2% Revenue Growth (next year): 2.69%

AI-Powered PBH Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 76.55%
76.55%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Prestige Consumer Healthcare Inc. (PBH)

BYOM JOHN E

Director

Sell
PBH Nov 25, 2025

Avg Cost/Share

$59.35

Shares

3,000

Total Value

$178,050.00

Owned After

51,594

SEC Form 4

Share on Social Networks: